drugset / Trial / NCT00542087

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

NCT00542087

Phase 3 Completed 516 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the safety and tolerability of etoricoxib and diclofenac sodium in the treatment of osteoarthritis of the knee or hip during a six week period.

Timeline

Start
2002-03-22
Primary completion
2002-12-20
Completion
2002-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 150 mg
Subject Etoricoxib Small molecule 60 mg

Indications